REDEFINE 1: Strong Results, Missed Ambitions The first pivotal trial, REDEFINE 1, enrolled 3,417 adults with obesity or overweight and at least one weight-related comorbidity, but without type 2 diabetes
In particular, for patients who do not respond to conventional therapies, the regulatory mechanisms of the BGA may represent important intervention targets (Figure 1)
Dana Taylor: Some patients told you they feel they're grasping at straws
The result may be what are commonly called glutathione detox symptoms: fatigue, mild nausea, headaches, or that general feeling of being "off" as your system works overtime
Somatostatin (AGCKNFFWKTFTSC) is a peptide produced by paracrine cells located throughout the gastrointestinal tract and binds to somatostatin receptors (SSTRs)
Significant weight loss typically only occurs once the patient has reached the maximum dose